Amandine Baurand
Dijon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Should PNPO Deficiency Be Treated In Utero? Clinical Findings From Prenatal Pyridoxine Therapy.
Journal: JIMD reports
Published: January 22, 2026
Genomic pathway managers: a novel role in the genomic medicine care pathway in France-overview and perspectives.
Journal: European journal of human genetics : EJHG
Published: March 19, 2025
MLH1 Constitutional Epimutation Screening Requires Highly Sensitive Assays to Identify Lynch Syndrome Patients With Very Low Mosaic Methylation Level.
Journal: Human mutation
Published: November 29, 2024
Cardiogenetics and uncertainty: Evaluation of professional vulnerability in France.
Journal: European journal of medical genetics
Published: April 21, 2024
Expectations, needs and mid-term outcomes in people accessing to secondary findings from ES: 1st French mixed study (FIND Study).
Journal: European journal of human genetics : EJHG
Published: November 13, 2023
Patient satisfaction, experience and preferences in the implementation of genetics teleconsultations in the North-eastern region of France.
Journal: European journal of medical genetics
Published: June 13, 2023
The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles.
Journal: Oncotarget
Published: February 07, 2023
Incidental findings in a series of 2500 gene panel tests for a genetic predisposition to cancer: Results and impact on patients.
Journal: European journal of medical genetics
Published: September 06, 2020
GEMO, a National Resource to Study Genetic Modifiers of Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Pathogenic Variant Carriers.
Journal: Frontiers in oncology
Published: July 01, 2018
Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.
Journal: European journal of medical genetics
Published: February 20, 2018
The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
Journal: Oncotarget
Published: March 08, 2016
Last Updated: 09/26/2026